Kees J schreef op 31 oktober 2023 07:34:
Oct 31 (Reuters) - The Dutch and Swiss chemicals maker DSM-Firmenich said on Tuesday it now expects its full-year core profit to come in at the low end of its initial guidance, due to a continued negative impact from its vitamin operations.
The company expects to report "around" 1.8 billion euros in adjusted earnings before interest, taxes, depreciation, and amortisation (EBITDA), against a previous estimate of between 1.8 and 1.9 billion euros.